140 related articles for article (PubMed ID: 38729531)
1. Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC-MS / MS.
Abdelgadir EH; Alshehri SD; Kumar S
J Pharmacol Toxicol Methods; 2024; 127():107513. PubMed ID: 38729531
[TBL] [Abstract][Full Text] [Related]
2. Rapid Simultaneous Determination of Three Synthetic Cannabinoids in Urine and Plasma of Rats Using Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.
Ke X; Tian Y; He D; Mu P; Wan X; Zhang L; Jia W; Wang Q; Fan Y; Zhang Y
Toxics; 2022 Oct; 10(10):. PubMed ID: 36287899
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
4. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Adamowicz P; Meissner E; Maślanka M
Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
[No Abstract] [Full Text] [Related]
5. In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.
Fabregat-Safont D; Mata-Pesquera M; Barneo-Muñoz M; Martinez-Garcia F; Mardal M; Davidsen AB; Sancho JV; Hernández F; Ibáñez M
Commun Biol; 2022 Feb; 5(1):161. PubMed ID: 35210552
[TBL] [Abstract][Full Text] [Related]
6. Post-aggression suicide under the influence of new psychoactive substances AMB-FUBINACA and U-47700.
Romańczuk A; Rojek S; Kula K; Maciów-Głąb M; Synowiec K; Moskała A; Rzepecka-Woźniak E; Kłys M
Leg Med (Tokyo); 2022 May; 56():102053. PubMed ID: 35279624
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
[TBL] [Abstract][Full Text] [Related]
8. Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions.
Franz F; Haschimi B; King LA; Auwärter V
Drug Test Anal; 2020 Mar; 12(3):391-396. PubMed ID: 31944614
[TBL] [Abstract][Full Text] [Related]
9. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
11. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
[TBL] [Abstract][Full Text] [Related]
12. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism.
Finlay DB; Mackie W; Webb HDJ; Thomsen LR; Nimick M; Rosengren RJ; Marusich JA; Glass M; Wiley JL
Pharmacol Biochem Behav; 2023 Feb; 223():173530. PubMed ID: 36805861
[TBL] [Abstract][Full Text] [Related]
13. A validated HPLC-ESI-MS/MS method for quantification of 2-hydroxy-4-methoxy benzoic acid from rat plasma and its application to pharmacokinetic study using sparse sampling methodology.
Nair SN; Mhatre M; Menon S; Shailajan S
J Pharm Biomed Anal; 2014 Nov; 100():190-198. PubMed ID: 25168218
[TBL] [Abstract][Full Text] [Related]
14. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
16.
Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.
Liu MY; Meng SN; Wu HZ; Wang S; Wei MJ
Clin Ther; 2008 Apr; 30(4):641-53. PubMed ID: 18498913
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant.
Ravula A; Chandasana H; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
J Pharm Biomed Anal; 2018 Oct; 160():119-125. PubMed ID: 30077950
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a HPLC-MS/MS method for the determination of phytolaccagenin in rat plasma and application to a pharmacokinetic study.
Wei F; Singh RS; Fueth M; Swarts S; Okunieff P; Derendorf H
J Pharm Biomed Anal; 2015 Mar; 107():82-8. PubMed ID: 25575173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
